Results 101 to 110 of about 1,455 (196)

Nonischemic Cardiac Manifestations in VEXAS Syndrome

open access: yesJAMA Network Open
This case series reports on the clinical presentation, laboratory findings, imaging characteristics, treatments, and outcomes of nonischemic cardiac manifestations in patients with VEXAS syndrome with confirmed pathogenic UBA1 alterations.
Robert, Marie   +75 more
openaire   +3 more sources

VEXAS syndrome: Focus on dermatological manifestations and their histopathological correlate

open access: yesJEADV Clinical Practice
Background VEXAS ‘Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome’ is a rare autoinflammatory syndrome, first described in October 2020 by Beck et al.
Sofie Engelen   +10 more
doaj   +1 more source

Clonal haematopoiesis across the age spectrum of vasculitis patients with Takayasus arteritis, ANCA-associated vasculitis and giant cell arteritis. [PDF]

open access: yes
OBJECTIVES: Ageing and inflammation are associated with clonal haematopoiesis (CH), the emergence of somatic mutations in haematopoietic cells. This study details CH in patients with systemic vasculitis in association with clinical, haematological and ...
Alemu, Lemlem   +12 more
core   +1 more source

Issue Information

open access: yes
Rheumatology &Autoimmunity, Volume 6, Issue 1, March 2026.
wiley   +1 more source

Intrapatient competition of VEXAS syndrome and CML clones [PDF]

open access: yes, 2023
Balabanov, Stefan   +5 more
core   +1 more source

VEXAS without vacuoles: Linking genotype to phenotype

open access: yeseJHaem
Introduction VEXAS syndrome is a rare condition characterized by somatic mutations in the ubiquitin‐like modifier activating enzyme 1 (UBA1) gene and a constellation of clinical/morphologic findings, including the presence of cytoplasmic vacuoles within ...
Sara Zhukovsky   +3 more
doaj   +1 more source

Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review

open access: yesFrontiers in Oncology
Vacuoles, E1 syndrome, X-linked, autoinflammatory, somatic (VEXAS) syndrome is a chronic inflammatory disorder that affects various organ systems. It is associated with hematologic malignancies and is generally refractory to therapies.
Polina Bellman   +12 more
doaj   +1 more source

Novel insights into the clinical features, genetic spectrum and clonal evolution of patients carrying NLRP3 mosaicism [PDF]

open access: yes
NLRP3 mosaicism is a well-established mechanism causing the monogenic autoinflammatory disease named cryopyrin associated periodic syndromes (CAPS). The number of reported patients with NLRP3 mosaicism is small, and the knowl edge about the long-term ...
Andreu Barasoain, Marta   +19 more
core   +1 more source

Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome presenting as recurrent aseptic peritonitis in a patient receiving peritoneal dialysis: a case report

open access: yesBMC Nephrology
Background Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is caused by mutations in the ubiquitin-activating enzyme1 (UBA1) gene and characterised by an overlap between autoinflammatory and haematologic disorders.
Natsuki Fukuda   +10 more
doaj   +1 more source

Azacytidine Treatment for VEXAS Syndrome

open access: yesHemaSphere, 2021
Raaijmakers, Marc   +6 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy